ALLIGENT BIOPHARM CONSULTING (EUROPE) LIMITED
Company Documents
| Date | Description |
|---|---|
| 22/04/2522 April 2025 | Confirmation statement made on 2025-04-20 with no updates |
| 28/02/2528 February 2025 | Director's details changed for Stanford Benjamin Rudnick on 2024-12-09 |
| 10/02/2510 February 2025 | Appointment of Stanford Benjamin Rudnick as a director on 2024-12-09 |
| 24/01/2524 January 2025 | Termination of appointment of Joshua Hollis Korth as a director on 2024-11-15 |
| 24/01/2524 January 2025 | Termination of appointment of Howard Collins Miller Iii as a director on 2024-12-31 |
| 29/10/2429 October 2024 | Appointment of Mr. Adam Brent Deutsch as a director on 2024-08-20 |
| 25/04/2425 April 2024 | Confirmation statement made on 2024-04-20 with no updates |
| 23/04/2423 April 2024 | Director's details changed for Mr Joshua Hollis Korth on 2021-12-14 |
| 22/04/2422 April 2024 | Change of details for Envision Pharma Bidco Limited as a person with significant control on 2016-04-21 |
| 27/09/2327 September 2023 | Appointment of Mr Howard Collins Miller Iii as a director on 2023-09-12 |
| 26/09/2326 September 2023 | |
| 26/09/2326 September 2023 | Termination of appointment of Margaret Heim as a director on 2023-08-02 |
| 26/09/2326 September 2023 | Audit exemption subsidiary accounts made up to 2022-12-31 |
| 26/09/2326 September 2023 | |
| 26/09/2326 September 2023 | |
| 26/04/2326 April 2023 | Confirmation statement made on 2023-04-20 with updates |
| 22/03/2322 March 2023 | Appointment of Mrs Margaret Heim as a director on 2023-02-21 |
| 24/02/2324 February 2023 | Statement of capital following an allotment of shares on 2023-02-06 |
| 21/09/2221 September 2022 | Audit exemption subsidiary accounts made up to 2021-12-31 |
| 21/09/2221 September 2022 | |
| 21/09/2221 September 2022 | |
| 21/09/2221 September 2022 | |
| 27/04/2227 April 2022 | Confirmation statement made on 2022-04-20 with updates |
| 26/04/2226 April 2022 | Statement of capital following an allotment of shares on 2021-06-30 |
| 17/01/2217 January 2022 | |
| 17/01/2217 January 2022 | |
| 17/01/2217 January 2022 | |
| 17/01/2217 January 2022 | Audit exemption subsidiary accounts made up to 2020-12-31 |
| 12/01/2212 January 2022 | Termination of appointment of Michael Irvine Mortimer as a director on 2021-12-14 |
| 12/01/2212 January 2022 | Termination of appointment of Andrea Ponti as a director on 2021-12-14 |
| 11/01/2211 January 2022 | Appointment of Mr Joshua Hollis Korth as a director on 2021-12-14 |
| 24/09/2124 September 2021 | Termination of appointment of John David Gillie as a director on 2021-08-10 |
| 12/07/1912 July 2019 | AUDIT EXEMPTION STATEMENT OF GUARANTEE BY PARENT COMPANY FOR PERIOD ENDING 31/12/18 |
| 12/07/1912 July 2019 | NOTICE OF AGREEMENT TO EXEMPTION FROM AUDIT OF ACCOUNTS FOR PERIOD ENDING 31/12/18 |
| 12/07/1912 July 2019 | AUDIT EXEMPTION SUBSIDIARY ACCOUNTS MADE UP TO 31/12/18 |
| 12/07/1912 July 2019 | CONSOLIDATED ACCOUNTS OF PARENT COMPANY FOR SUBSIDIARY COMPANY PERIOD ENDING 31/12/18 |
| 21/06/1921 June 2019 | 29/05/19 STATEMENT OF CAPITAL USD 262766211.54 |
| 01/05/191 May 2019 | CONFIRMATION STATEMENT MADE ON 20/04/19, NO UPDATES |
| 13/12/1813 December 2018 | APPOINTMENT TERMINATED, DIRECTOR SIMON LYALL-COTTLE |
| 13/12/1813 December 2018 | DIRECTOR APPOINTED MR BENJAMIN MAURICE FREDERICK WITCHER |
| 05/10/185 October 2018 | AUDIT EXEMPTION SUBSIDIARY ACCOUNTS MADE UP TO 31/12/17 |
| 05/10/185 October 2018 | CONSOLIDATED ACCOUNTS OF PARENT COMPANY FOR SUBSIDIARY COMPANY PERIOD ENDING 31/12/17 |
| 24/09/1824 September 2018 | AUDIT EXEMPTION STATEMENT OF GUARANTEE BY PARENT COMPANY FOR PERIOD ENDING 31/12/17 |
| 24/09/1824 September 2018 | NOTICE OF AGREEMENT TO EXEMPTION FROM AUDIT OF ACCOUNTS FOR PERIOD ENDING 31/12/17 |
| 15/05/1815 May 2018 | CONFIRMATION STATEMENT MADE ON 20/04/18, NO UPDATES |
| 10/10/1710 October 2017 | AUDIT EXEMPTION STATEMENT OF GUARANTEE BY PARENT COMPANY FOR PERIOD ENDING 31/12/16 |
| 10/10/1710 October 2017 | NOTICE OF AGREEMENT TO EXEMPTION FROM AUDIT OF ACCOUNTS FOR PERIOD ENDING 31/12/16 |
| 10/10/1710 October 2017 | CONSOLIDATED ACCOUNTS OF PARENT COMPANY FOR SUBSIDIARY COMPANY PERIOD ENDING 31/12/16 |
| 10/10/1710 October 2017 | AUDIT EXEMPTION SUBSIDIARY ACCOUNTS MADE UP TO 31/12/16 |
| 04/05/174 May 2017 | CONFIRMATION STATEMENT MADE ON 20/04/17, WITH UPDATES |
| 27/04/1727 April 2017 | REGISTER(S) MOVED TO SAIL ADDRESS 114-REG MEM 162-REG DIR 275-REG SEC REG PSC |
| 27/04/1727 April 2017 | SAIL ADDRESS CREATED |
| 02/03/172 March 2017 | DIRECTOR'S CHANGE OF PARTICULARS / JOHN DAVID GILLE / 06/07/2016 |
| 02/03/172 March 2017 | COMPANY NAME CHANGED TYROL ACQUISITIONCO LIMITED CERTIFICATE ISSUED ON 02/03/17 |
| 13/09/1613 September 2016 | 06/07/16 STATEMENT OF CAPITAL USD 116299244.37 |
| 20/07/1620 July 2016 | REGISTERED OFFICE CHANGED ON 20/07/2016 FROM 1 GRAFTON STREET LONDON W1S 4FE UNITED KINGDOM |
| 20/07/1620 July 2016 | DIRECTOR APPOINTED JOHN DAVID GILLE |
| 05/07/165 July 2016 | REGISTRATION OF A CHARGE / CHARGE CODE 101387010001 |
| 06/06/166 June 2016 | STATEMENT BY DIRECTORS |
| 06/06/166 June 2016 | SOLVENCY STATEMENT DATED 26/05/16 |
| 06/06/166 June 2016 | 26/05/16 STATEMENT OF CAPITAL USD 0.014482 |
| 06/06/166 June 2016 | 06/06/16 STATEMENT OF CAPITAL USD 0.01 |
| 06/06/166 June 2016 | RESOLUTION TO REDENOMINATE SHARES 26/05/2016 |
| 21/04/1621 April 2016 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
| 21/04/1621 April 2016 | CURRSHO FROM 30/04/2017 TO 31/12/2016 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company